InMed Pharmaceuticals
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell INM and other ETFs, options, and stocks.About INM
InMed Pharmaceuticals, Inc. is a pharmaceutical drug development company, which engages in developing small molecule drug candidates that are preferential signaling ligands of the endogenous CB1 and CB2 receptors as well as other receptor targets linked to human disease. The company was founded by Christopher Bogart, Sazzad Hossain, Hyder A.
INM Key Statistics
Stock Snapshot
As of today, InMed Pharmaceuticals(INM) shares are valued at $1.45. The company's market cap stands at 7.58M, with a P/E ratio of -0.44.
On 2026-09-21, InMed Pharmaceuticals(INM) stock opened at $1.39, reached a high of —, and a low of —.
The InMed Pharmaceuticals(INM)'s current trading volume is 544, compared to an average daily volume of 69.56K.
During the past year, InMed Pharmaceuticals(INM) stock moved between $0.58 at its lowest and $2.50 at its peak.
During the past year, InMed Pharmaceuticals(INM) stock moved between $0.58 at its lowest and $2.50 at its peak.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.